Cramer s Mad Money Recap: Brunswick, Clorox, Logitech
Another heavy week of financial reports is on tap and Jim Cramer s got the details on who and what to watch for.
Author:
Apr 30, 2021 8:14 PM EDT
Next week is another week of rapid-fire earnings reports, Jim Cramer told his Mad Money viewers Friday. That means investors need to keep their eyes open for stocks that decline on great earnings and do some buying.
Cramer s game plan next week starts off on Monday with earns from Estee Lauder (
FANG) - Get Report, along with an analyst meeting from Merck (
MRK) - Get Report. Estee Lauder and Diamondback should be strong, but investors should just listen to what Merck has to say.
Share this article
Share this article
NEW YORK, April 26, 2021 /PRNewswire/ Pomerantz LLP announces that a class action lawsuit has been filed against Acadia Pharmaceuticals Inc. ( Acadia or the Company ) (NASDAQ: ACAD) and certain of its officers. The class action, filed in the United States District Court for the Southern District of California, and docketed under 21-cv-00762, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Acadia securities between June 15, 2020 and April 4, 2021, both dates inclusive (the Class Period ), seeking to recover damages caused by Defendants violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the Exchange Act ) and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Acadia Pharmaceuticals Inc of Class Action Lawsuit and Upcoming Deadline prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Acadia Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline – ACAD
04/24/2021 | 11:17pm EDT
Send by mail :
Message :
Required fields
NEW YORK, April 24, 2021 (GLOBE NEWSWIRE) Pomerantz LLP announces that a class action lawsuit has been filed against Acadia Pharmaceuticals Inc. (“Acadia” or the “Company”)(NASDAQ: ACAD) and certain of its officers. The class action, filed in the United States District Court for the Southern District of California, and docketed under 21-cv-00762, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Acadia securities between June 15, 2020 and April 4, 2021, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Sec
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Acadia Pharmaceuticals Inc of Class Action Lawsuit and Upcoming Deadline – ACAD globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.